Case number 1:17-cv-06557
Valeant Pharmaceuticals International, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 4, 2017 | 20 | Notice of Voluntary Dismissal - Signed (1) Docket Text: NOTICE OF VOLUNTARY DISMISSAL WITHOUT PREJUDICE PURSUANT TO F.R.C.P. 41(a)(1): Pursuant to Federal Rule of Civil Procedure 41(a)(1), Plaintiffs Valeant Pharmaceuticals International, Inc., Salix Pharmaceuticals, Inc., Progenics Pharmaceuticals, Inc. and Wyeth LLC, voluntarily dismiss this action all Defendants without prejudice. Defendants have not filed an answer or a motion for summary judgment. SO ORDERED. (Signed by Judge Paul A. Engelmayer on 12/4/2017) (anc) |
| Dec 1, 2017 | 19 | AO 120 Form Trademark - Case Terminated - Submitted (2) Docket Text: AO 120 FORM TRADEMARK - CASE TERMINATED - SUBMITTED. In compliance with the provisions of 15 U.S.C. 1116, the Director of the U.S. Patent and Trademark Office is hereby advised that a final decision was rendered on 11/30/2017 in a court action filed on the following trademark(s) in the U.S. District Court Southern District of New York. Director of the U.S. Patent and Trademark Office electronically notified via Notice of Electronic Filing (NEF). (km) |
| Nov 30, 2017 | 18 | Notice of Voluntary Dismissal (1) Docket Text: NOTICE OF VOLUNTARY DISMISSAL Pursuant to Rule 41(a)(1)(A)(i) of the Federal Rules of Civil Procedure, the plaintiff(s) and or their counsel(s), hereby give notice that the above-captioned action is voluntarily dismissed, Without prejudice against the defendant(s) All Defendants. Document filed by All Plaintiffs. (LaSala, Joseph) |
| Sep 7, 2017 | N/A | Notice of Case Assignment/Reassignment (0) Docket Text: NOTICE OF CASE REASSIGNMENT to Judge Paul A. Engelmayer. Judge Katherine Polk Failla is no longer assigned to the case. (ma) |
| Aug 29, 2017 | N/A | Notice to Attorney to Re-File Document - Deficient Docket Entry Error (0) Docket Text:***NOTICE TO ATTORNEY TO RE-FILE DOCUMENT - DEFICIENT DOCKET ENTRY ERROR. Notice to Attorney Joseph P. LaSala to RE-FILE Document [3] Rule 7.1 Corporate Disclosure Statement,. ERROR(S): Corporate Parents were not added. Please re-file this document and when prompted: Are there any corporate parents or other affiliates?, select the YES radio button and enter the Corporate Parent(s) or Affiliate(s). YOU MUST SELECT THE SEARCH BUTTON. Select the correct name or create a new corporate parent. Add the Corporate Parent(s) or Affiliate(s) one party name at a time. (lb) |
| Aug 29, 2017 | 17 | Civil Cover Sheet (2) Docket Text: CIVIL COVER SHEET filed. (LaSala, Joseph) |
| Aug 29, 2017 | 16 | Summons Issued (2) Docket Text: ELECTRONIC SUMMONS ISSUED as to Endo International PLC. (rch) |
| Aug 29, 2017 | 15 | Summons Issued (2) Docket Text: ELECTRONIC SUMMONS ISSUED as to Par Pharmaceutical, Inc.. (rch) |
| Aug 29, 2017 | 14 | Summons Issued (2) Docket Text: ELECTRONIC SUMMONS ISSUED as to Par Sterile Products, LLC. (rch) |
| Aug 29, 2017 | 13 | Mail Patent Form (case opening) (2) Docket Text: AO 120 FORM PATENT - CASE OPENING - SUBMITTED. In compliance with the provisions of 35 U.S.C. 290, the Director of the U.S. Patent and Trademark Office is hereby advised that a court action has been filed on the following patent(s) in the U.S. District Court Southern District of New York. Director of the U.S. Patent and Trademark Office electronically notified via Notice of Electronic Filing (NEF). (rch) |
| Aug 29, 2017 | 12 | Rule 7.1 Corporate Disclosure Statement (3) Docket Text: RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Corporate Parent Salix Pharmaceuticals, Ltd., Corporate Parent Biovail Americas Corp., Corporate Parent V-Bac Holdings Corp., Corporate Parent Valeant Canada LP for Salix Pharmaceuticals, Inc.; Corporate Parent Federated Investors Inc. for Progenics Pharmaceuticals, Inc.. Document filed by Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc..(LaSala, Joseph) |
| Aug 29, 2017 | N/A | Case Designated ECF (0) Docket Text: Case Designated ECF. (rch) |
| Aug 29, 2017 | N/A | Case Designation (0) Docket Text: Magistrate Judge Debra C. Freeman is so designated. Pursuant to 28 U.S.C. Section 636(c) and Fed. R. Civ. P. 73(b)(1) parties are notified that they may consent to proceed before a United States Magistrate Judge. Parties who wish to consent may access the necessary form at the following link: http://nysd.uscourts.gov/forms.php. (rch) |
| Aug 29, 2017 | N/A | Case Opening Initial Assignment Notice (0) Docket Text: CASE OPENING INITIAL ASSIGNMENT NOTICE: The above-entitled action is assigned to Judge Katherine Polk Failla. Please download and review the Individual Practices of the assigned District Judge, located at http://nysd.uscourts.gov/judges/District. Attorneys are responsible for providing courtesy copies to judges where their Individual Practices require such. Please download and review the ECF Rules and Instructions, located at http://nysd.uscourts.gov/ecf_filing.php. (rch) |
| Aug 29, 2017 | N/A | Case Designated Patent Pilot Program (0) Docket Text: Case Eligible for Patent Pilot Program. (rch) |
| Aug 29, 2017 | N/A | Notice to Attorney Regarding Deficient Civil Cover Sheet (0) Docket Text:***NOTICE TO ATTORNEY REGARDING DEFICIENT CIVIL COVER SHEET. Notice to attorney Joseph P. LaSala to RE-FILE Document No. [2] Civil Cover Sheet. The filing is deficient for the following reason(s): the form used for the civil cover sheet is not the S.D.N.Y. Civil Cover Sheet form dated June 2017. Re-file the document using the event type Civil Cover Sheet found under the event list Other Documents and attach the correct PDF. Use civil cover sheet issued by S.D.N.Y. dated June 2017. The S.D.N.Y. Civil Cover Sheet dated June 2017 is located at http://nysd.uscourts.gov/file/forms/civil-cover-sheet.. (rch) |
| Aug 28, 2017 | 11 | Request for Issuance of Summons (2) Docket Text: REQUEST FOR ISSUANCE OF SUMMONS as to Endo International plc, re: [1] Complaint,. Document filed by Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Wyeth LLC. (LaSala, Joseph) |
| Aug 28, 2017 | 1 | Complaint (20) |
| Aug 28, 2017 | 10 | Request for Issuance of Summons (2) Docket Text: REQUEST FOR ISSUANCE OF SUMMONS as to Par Pharmaceutical, Inc., re: [1] Complaint,. Document filed by Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Wyeth LLC. (LaSala, Joseph) |
| Aug 28, 2017 | 9 | Request for Issuance of Summons (2) Docket Text: REQUEST FOR ISSUANCE OF SUMMONS as to Par Sterile Products, LLC, re: [1] Complaint,. Document filed by Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Wyeth LLC. (LaSala, Joseph) |
| Aug 28, 2017 | 8 | Statement of Relatedness (2) Docket Text: STATEMENT OF RELATEDNESS re: that this action be filed as related to 2:17-cv-06449-SRC-CLW. Document filed by Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Wyeth LLC.(LaSala, Joseph) |
| Aug 28, 2017 | 7 | Statement of Relatedness (2) Docket Text: STATEMENT OF RELATEDNESS re: that this action be filed as related to 2:16-cv-09038-SRC-CLW. Document filed by Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Wyeth LLC.(LaSala, Joseph) |
| Aug 28, 2017 | 6 | Statement of Relatedness (2) Docket Text: STATEMENT OF RELATEDNESS re: that this action be filed as related to 2:15-cv-08180-SRC-CLW. Document filed by Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Wyeth LLC.(LaSala, Joseph) |
| Aug 28, 2017 | 5 | AO 120 Form Patent/Trademark - Notice of Submission by Attorney (2) Docket Text: AO 120 FORM PATENT - NOTICE OF SUBMISSION BY ATTORNEY. AO 120 Form Patent/Trademark for case opening submitted to court for review.(LaSala, Joseph) |
| Aug 28, 2017 | 4 | Rule 7.1 Corporate Disclosure Statement (1) Docket Text: RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Corporate Parent Pfizer Inc. for Wyeth LLC. Document filed by Wyeth LLC.(LaSala, Joseph) |
| Aug 28, 2017 | 3 | Rule 7.1 Corporate Disclosure Statement (3) Docket Text:FILING ERROR - CORPORATE PARENT/OTHER AFFILIATE NOT ADDED - RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc..(LaSala, Joseph) Modified on 8/29/2017 (lb). |
| Aug 28, 2017 | 2 | Civil Cover Sheet (1) Docket Text: FILING ERROR - DEFICIENT PLEADING - CIVIL COVER SHEET - WRONG CIVIL COVER SHEET FORM - CIVIL COVER SHEET filed. (LaSala, Joseph) Modified on 8/29/2017 (rch). |
| Aug 28, 2017 | 1 | Exhibit F (28) |
| Aug 28, 2017 | 1 | Exhibit E (52) |
| Aug 28, 2017 | 1 | Exhibit D (53) |
| Aug 28, 2017 | 1 | Exhibit C (25) |
| Aug 28, 2017 | 1 | Exhibit B (52) |
| Aug 28, 2017 | 1 | Exhibit A (52) |
| Aug 28, 2017 | 1 | Main Document (20) Docket Text: COMPLAINT against Par Sterile Products, LLC, Par Pharmaceutical, Inc., Endo International PLC. (Filing Fee $ 400.00, Receipt Number 0208-14064402)Document filed by Wyeth LLC, Valeant Pharmaceuticals International, Inc., Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F)(LaSala, Joseph) |
